Autonomix Medical, Inc. (AMIX)
NASDAQ: AMIX · Real-Time Price · USD
9.29
-0.75 (-7.47%)
At close: Aug 10, 2026, 4:00 PM EDT
9.00
-0.29 (-3.12%)
Pre-market: Aug 11, 2026, 9:12 AM EDT

Autonomix Medical Income Statement

Millions USD. Fiscal year is Apr - Mar.
Fiscal Year
FY 2026FY 2025FY 2024FY 2023
Period Ending
Mar '26 Mar '25 Mar '24 Mar '23
Selling, General & Admin
9.896.865.251.25
Research & Development
7.144.732.230.75
Other Operating Expenses
--4.56-
Total Operating Expenses
17.0311.5912.031.99
Operating Income
-17.03-11.59-12.03-1.99
Interest Income
0.320.350.13-
Interest Expense
--0.18-0.08-
Other Non-Operating Income (Expense)
---3.44-
Total Non-Operating Income (Expense)
0.320.18-3.4-
Pretax Income
-16.72-11.41-15.43-1.99
Net Income
-16.72-11.41-15.43-1.99
Net Income to Common
-16.72-11.41-15.43-1.99
Net Income Growth
----
Shares Outstanding (Basic)
0000
Shares Outstanding (Diluted)
0000
Shares Change
308.55%69.73%73.12%-
EPS (Basic)
-48.72-135.66-311.22-69.51
EPS (Diluted)
-48.72-135.66-311.22-69.51
EPS Growth
----
Free Cash Flow
-12.29-8.27-6.67-1.85
Free Cash Flow Growth
----
Free Cash Flow Per Share
-35.77-98.34-134.53-64.76
EBITDA
-17.02-11.41-11.95-1.99
EBIT
-17.03-11.59-12.03-1.99
SEC Filings: 10-K · 10-Q